Enhanced DNA-repair capacity and resistance to chemically induced carcinogenesis upon deletion of the phosphatase regulator NIPP1

Nuclear Inhibitor of PP1 (NIPP1) is a conserved regulatory subunit of protein phosphatase PP1. The selective deletion of NIPP1 in mouse liver parenchymal cells or skin epidermal cells culminates in a late-onset hyperproliferation of a subset of resident progenitor cells. Although a hyperplastic phen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncogenesis (New York, NY) NY), 2020-03, Vol.9 (3), p.30, Article 30
Hauptverfasser: Verbinnen, Iris, Boens, Shannah, Ferreira, Monica, Szekér, Kathelijne, Van Wijk, Louise, Van Eynde, Aleyde, Bollen, Mathieu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 3
container_start_page 30
container_title Oncogenesis (New York, NY)
container_volume 9
creator Verbinnen, Iris
Boens, Shannah
Ferreira, Monica
Szekér, Kathelijne
Van Wijk, Louise
Van Eynde, Aleyde
Bollen, Mathieu
description Nuclear Inhibitor of PP1 (NIPP1) is a conserved regulatory subunit of protein phosphatase PP1. The selective deletion of NIPP1 in mouse liver parenchymal cells or skin epidermal cells culminates in a late-onset hyperproliferation of a subset of resident progenitor cells. Although a hyperplastic phenotype is usually tumor promoting, we show here that the absence of NIPP1 conferred a strong resistance to chemically induced hepatocellular or skin carcinoma. The ablation of NIPP1 did not affect the metabolism of the administered mutagens (diethylnitrosamine or 7,12-dimethylbenz[a]anthracene), but reduced the conversion of mutagen-induced covalent DNA modifications into cancer-initiating mutations. This reduced sensitivity to mutagens correlated with an enhanced DNA-damage response and an augmented expression of rate-limiting DNA-repair proteins (MGMT in liver, XPD and XPG in skin), hinting at an increased DNA-repair capacity. Our data identify NIPP1 as a repressor of DNA repair and as a promising target for novel cancer prevention and treatment therapies.
doi_str_mv 10.1038/s41389-020-0214-3
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7051951</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2369858511</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-63918c55b454fd0d7b891f499ef3358ac66c6614f0c3d1d0f99bc876d498f1923</originalsourceid><addsrcrecordid>eNp1kUFrHSEUhaU0NCHJD-imCF1P6x11RjeFkKZtIKRZJGvxqfPGME-n6hTesv-8Di9N00VF8cL9zrkXDkJvgXwAQsXHzIAK2ZCW1Aesoa_QSQu8byRp2esX9TE6z_mR1MM76Dh_g45pCy0FLk_Qr6sw6mCcxZ9vL5rkZu0TNnrWxpc91sHi5LLPZWVwidiMbueNnqY99sEuq9DoZHyIWxdWEi9zDNi6yRVfizjgMjo8jzHPoy46u2q4XSZdYsK313d3cIaOBj1ld_70n6KHL1f3l9-am-9fry8vbhrDelKajkoQhvMN42ywxPYbIWFgUrqBUi606bp6gQ3EUAuWDFJujOg7y6QYQLb0FH06-M7LZuescaEkPak5-Z1OexW1V_92gh_VNv5UPeEgOVSD908GKf5YXC7qMS4p1J1VSzspuOCwUnCgTIo5Jzc8TwCi1uDUIThVg1NrcIpWzbuXqz0r_sRUgfYA5NoKW5f-jv6_629QpaVW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2369858511</pqid></control><display><type>article</type><title>Enhanced DNA-repair capacity and resistance to chemically induced carcinogenesis upon deletion of the phosphatase regulator NIPP1</title><source>Nature Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Springer Nature OA/Free Journals</source><source>PubMed Central Open Access</source><creator>Verbinnen, Iris ; Boens, Shannah ; Ferreira, Monica ; Szekér, Kathelijne ; Van Wijk, Louise ; Van Eynde, Aleyde ; Bollen, Mathieu</creator><creatorcontrib>Verbinnen, Iris ; Boens, Shannah ; Ferreira, Monica ; Szekér, Kathelijne ; Van Wijk, Louise ; Van Eynde, Aleyde ; Bollen, Mathieu</creatorcontrib><description>Nuclear Inhibitor of PP1 (NIPP1) is a conserved regulatory subunit of protein phosphatase PP1. The selective deletion of NIPP1 in mouse liver parenchymal cells or skin epidermal cells culminates in a late-onset hyperproliferation of a subset of resident progenitor cells. Although a hyperplastic phenotype is usually tumor promoting, we show here that the absence of NIPP1 conferred a strong resistance to chemically induced hepatocellular or skin carcinoma. The ablation of NIPP1 did not affect the metabolism of the administered mutagens (diethylnitrosamine or 7,12-dimethylbenz[a]anthracene), but reduced the conversion of mutagen-induced covalent DNA modifications into cancer-initiating mutations. This reduced sensitivity to mutagens correlated with an enhanced DNA-damage response and an augmented expression of rate-limiting DNA-repair proteins (MGMT in liver, XPD and XPG in skin), hinting at an increased DNA-repair capacity. Our data identify NIPP1 as a repressor of DNA repair and as a promising target for novel cancer prevention and treatment therapies.</description><identifier>ISSN: 2157-9024</identifier><identifier>EISSN: 2157-9024</identifier><identifier>DOI: 10.1038/s41389-020-0214-3</identifier><identifier>PMID: 32123159</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>13/1 ; 13/51 ; 13/89 ; 631/67/70 ; 631/80 ; 64/60 ; 9,10-Dimethyl-1,2-benzanthracene ; Anthracene ; Apoptosis ; Brief Communication ; Carcinogenesis ; Cell Biology ; Clonal deletion ; Deoxyribonucleic acid ; Diethylnitrosamine ; DNA ; DNA damage ; DNA repair ; Hepatocytes ; Human Genetics ; Internal Medicine ; Medicine ; Medicine &amp; Public Health ; Mutagens ; O6-methylguanine-DNA methyltransferase ; Oncology ; Phenotypes ; Phosphatase ; Progenitor cells ; Protein phosphatase ; Skin cancer ; Skin carcinoma ; Stem cells ; XPD protein</subject><ispartof>Oncogenesis (New York, NY), 2020-03, Vol.9 (3), p.30, Article 30</ispartof><rights>The Author(s) 2020</rights><rights>This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-63918c55b454fd0d7b891f499ef3358ac66c6614f0c3d1d0f99bc876d498f1923</citedby><cites>FETCH-LOGICAL-c470t-63918c55b454fd0d7b891f499ef3358ac66c6614f0c3d1d0f99bc876d498f1923</cites><orcidid>0000-0001-9609-5099 ; 0000-0002-3462-4976 ; 0000-0003-4975-1510</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051951/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051951/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,41096,42165,51551,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32123159$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Verbinnen, Iris</creatorcontrib><creatorcontrib>Boens, Shannah</creatorcontrib><creatorcontrib>Ferreira, Monica</creatorcontrib><creatorcontrib>Szekér, Kathelijne</creatorcontrib><creatorcontrib>Van Wijk, Louise</creatorcontrib><creatorcontrib>Van Eynde, Aleyde</creatorcontrib><creatorcontrib>Bollen, Mathieu</creatorcontrib><title>Enhanced DNA-repair capacity and resistance to chemically induced carcinogenesis upon deletion of the phosphatase regulator NIPP1</title><title>Oncogenesis (New York, NY)</title><addtitle>Oncogenesis</addtitle><addtitle>Oncogenesis</addtitle><description>Nuclear Inhibitor of PP1 (NIPP1) is a conserved regulatory subunit of protein phosphatase PP1. The selective deletion of NIPP1 in mouse liver parenchymal cells or skin epidermal cells culminates in a late-onset hyperproliferation of a subset of resident progenitor cells. Although a hyperplastic phenotype is usually tumor promoting, we show here that the absence of NIPP1 conferred a strong resistance to chemically induced hepatocellular or skin carcinoma. The ablation of NIPP1 did not affect the metabolism of the administered mutagens (diethylnitrosamine or 7,12-dimethylbenz[a]anthracene), but reduced the conversion of mutagen-induced covalent DNA modifications into cancer-initiating mutations. This reduced sensitivity to mutagens correlated with an enhanced DNA-damage response and an augmented expression of rate-limiting DNA-repair proteins (MGMT in liver, XPD and XPG in skin), hinting at an increased DNA-repair capacity. Our data identify NIPP1 as a repressor of DNA repair and as a promising target for novel cancer prevention and treatment therapies.</description><subject>13/1</subject><subject>13/51</subject><subject>13/89</subject><subject>631/67/70</subject><subject>631/80</subject><subject>64/60</subject><subject>9,10-Dimethyl-1,2-benzanthracene</subject><subject>Anthracene</subject><subject>Apoptosis</subject><subject>Brief Communication</subject><subject>Carcinogenesis</subject><subject>Cell Biology</subject><subject>Clonal deletion</subject><subject>Deoxyribonucleic acid</subject><subject>Diethylnitrosamine</subject><subject>DNA</subject><subject>DNA damage</subject><subject>DNA repair</subject><subject>Hepatocytes</subject><subject>Human Genetics</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mutagens</subject><subject>O6-methylguanine-DNA methyltransferase</subject><subject>Oncology</subject><subject>Phenotypes</subject><subject>Phosphatase</subject><subject>Progenitor cells</subject><subject>Protein phosphatase</subject><subject>Skin cancer</subject><subject>Skin carcinoma</subject><subject>Stem cells</subject><subject>XPD protein</subject><issn>2157-9024</issn><issn>2157-9024</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kUFrHSEUhaU0NCHJD-imCF1P6x11RjeFkKZtIKRZJGvxqfPGME-n6hTesv-8Di9N00VF8cL9zrkXDkJvgXwAQsXHzIAK2ZCW1Aesoa_QSQu8byRp2esX9TE6z_mR1MM76Dh_g45pCy0FLk_Qr6sw6mCcxZ9vL5rkZu0TNnrWxpc91sHi5LLPZWVwidiMbueNnqY99sEuq9DoZHyIWxdWEi9zDNi6yRVfizjgMjo8jzHPoy46u2q4XSZdYsK313d3cIaOBj1ld_70n6KHL1f3l9-am-9fry8vbhrDelKajkoQhvMN42ywxPYbIWFgUrqBUi606bp6gQ3EUAuWDFJujOg7y6QYQLb0FH06-M7LZuescaEkPak5-Z1OexW1V_92gh_VNv5UPeEgOVSD908GKf5YXC7qMS4p1J1VSzspuOCwUnCgTIo5Jzc8TwCi1uDUIThVg1NrcIpWzbuXqz0r_sRUgfYA5NoKW5f-jv6_629QpaVW</recordid><startdate>20200302</startdate><enddate>20200302</enddate><creator>Verbinnen, Iris</creator><creator>Boens, Shannah</creator><creator>Ferreira, Monica</creator><creator>Szekér, Kathelijne</creator><creator>Van Wijk, Louise</creator><creator>Van Eynde, Aleyde</creator><creator>Bollen, Mathieu</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9609-5099</orcidid><orcidid>https://orcid.org/0000-0002-3462-4976</orcidid><orcidid>https://orcid.org/0000-0003-4975-1510</orcidid></search><sort><creationdate>20200302</creationdate><title>Enhanced DNA-repair capacity and resistance to chemically induced carcinogenesis upon deletion of the phosphatase regulator NIPP1</title><author>Verbinnen, Iris ; Boens, Shannah ; Ferreira, Monica ; Szekér, Kathelijne ; Van Wijk, Louise ; Van Eynde, Aleyde ; Bollen, Mathieu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-63918c55b454fd0d7b891f499ef3358ac66c6614f0c3d1d0f99bc876d498f1923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>13/1</topic><topic>13/51</topic><topic>13/89</topic><topic>631/67/70</topic><topic>631/80</topic><topic>64/60</topic><topic>9,10-Dimethyl-1,2-benzanthracene</topic><topic>Anthracene</topic><topic>Apoptosis</topic><topic>Brief Communication</topic><topic>Carcinogenesis</topic><topic>Cell Biology</topic><topic>Clonal deletion</topic><topic>Deoxyribonucleic acid</topic><topic>Diethylnitrosamine</topic><topic>DNA</topic><topic>DNA damage</topic><topic>DNA repair</topic><topic>Hepatocytes</topic><topic>Human Genetics</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mutagens</topic><topic>O6-methylguanine-DNA methyltransferase</topic><topic>Oncology</topic><topic>Phenotypes</topic><topic>Phosphatase</topic><topic>Progenitor cells</topic><topic>Protein phosphatase</topic><topic>Skin cancer</topic><topic>Skin carcinoma</topic><topic>Stem cells</topic><topic>XPD protein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Verbinnen, Iris</creatorcontrib><creatorcontrib>Boens, Shannah</creatorcontrib><creatorcontrib>Ferreira, Monica</creatorcontrib><creatorcontrib>Szekér, Kathelijne</creatorcontrib><creatorcontrib>Van Wijk, Louise</creatorcontrib><creatorcontrib>Van Eynde, Aleyde</creatorcontrib><creatorcontrib>Bollen, Mathieu</creatorcontrib><collection>Springer Nature OA/Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncogenesis (New York, NY)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Verbinnen, Iris</au><au>Boens, Shannah</au><au>Ferreira, Monica</au><au>Szekér, Kathelijne</au><au>Van Wijk, Louise</au><au>Van Eynde, Aleyde</au><au>Bollen, Mathieu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhanced DNA-repair capacity and resistance to chemically induced carcinogenesis upon deletion of the phosphatase regulator NIPP1</atitle><jtitle>Oncogenesis (New York, NY)</jtitle><stitle>Oncogenesis</stitle><addtitle>Oncogenesis</addtitle><date>2020-03-02</date><risdate>2020</risdate><volume>9</volume><issue>3</issue><spage>30</spage><pages>30-</pages><artnum>30</artnum><issn>2157-9024</issn><eissn>2157-9024</eissn><abstract>Nuclear Inhibitor of PP1 (NIPP1) is a conserved regulatory subunit of protein phosphatase PP1. The selective deletion of NIPP1 in mouse liver parenchymal cells or skin epidermal cells culminates in a late-onset hyperproliferation of a subset of resident progenitor cells. Although a hyperplastic phenotype is usually tumor promoting, we show here that the absence of NIPP1 conferred a strong resistance to chemically induced hepatocellular or skin carcinoma. The ablation of NIPP1 did not affect the metabolism of the administered mutagens (diethylnitrosamine or 7,12-dimethylbenz[a]anthracene), but reduced the conversion of mutagen-induced covalent DNA modifications into cancer-initiating mutations. This reduced sensitivity to mutagens correlated with an enhanced DNA-damage response and an augmented expression of rate-limiting DNA-repair proteins (MGMT in liver, XPD and XPG in skin), hinting at an increased DNA-repair capacity. Our data identify NIPP1 as a repressor of DNA repair and as a promising target for novel cancer prevention and treatment therapies.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>32123159</pmid><doi>10.1038/s41389-020-0214-3</doi><orcidid>https://orcid.org/0000-0001-9609-5099</orcidid><orcidid>https://orcid.org/0000-0002-3462-4976</orcidid><orcidid>https://orcid.org/0000-0003-4975-1510</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2157-9024
ispartof Oncogenesis (New York, NY), 2020-03, Vol.9 (3), p.30, Article 30
issn 2157-9024
2157-9024
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7051951
source Nature Open Access; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Springer Nature OA/Free Journals; PubMed Central Open Access
subjects 13/1
13/51
13/89
631/67/70
631/80
64/60
9,10-Dimethyl-1,2-benzanthracene
Anthracene
Apoptosis
Brief Communication
Carcinogenesis
Cell Biology
Clonal deletion
Deoxyribonucleic acid
Diethylnitrosamine
DNA
DNA damage
DNA repair
Hepatocytes
Human Genetics
Internal Medicine
Medicine
Medicine & Public Health
Mutagens
O6-methylguanine-DNA methyltransferase
Oncology
Phenotypes
Phosphatase
Progenitor cells
Protein phosphatase
Skin cancer
Skin carcinoma
Stem cells
XPD protein
title Enhanced DNA-repair capacity and resistance to chemically induced carcinogenesis upon deletion of the phosphatase regulator NIPP1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T21%3A14%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhanced%20DNA-repair%20capacity%20and%20resistance%20to%20chemically%20induced%20carcinogenesis%20upon%20deletion%20of%20the%20phosphatase%20regulator%20NIPP1&rft.jtitle=Oncogenesis%20(New%20York,%20NY)&rft.au=Verbinnen,%20Iris&rft.date=2020-03-02&rft.volume=9&rft.issue=3&rft.spage=30&rft.pages=30-&rft.artnum=30&rft.issn=2157-9024&rft.eissn=2157-9024&rft_id=info:doi/10.1038/s41389-020-0214-3&rft_dat=%3Cproquest_pubme%3E2369858511%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2369858511&rft_id=info:pmid/32123159&rfr_iscdi=true